Autoinflammatory Reaction in Dogs Treated for Cancer via G6PD Inhibition
Glucose-6-phosphate dehydrogenase (G6PD) is an oncoprotein that is overexpressed in cancer cells to provide the NADPH required for their increased anabolism. NADPH, sourced from G6PD fuels nucleotide biosynthesis, maintains redox potential of thioredoxin and glutathione and drives the mevalonate pat...
Saved in:
Main Author: | Jonathan W. Nyce |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Veterinary Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/4275305 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Untangling the Web of Systemic Autoinflammatory Diseases
by: Donato Rigante, et al.
Published: (2014-01-01) -
Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency
by: Boonchai Boonyawat, et al.
Published: (2021-01-01) -
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
by: Tzu-Ping Lin, et al.
Published: (2025-01-01) -
Attempts to identify the molecular cause of autoinflammatory recurrent fever
by: Oksana Boyarchuk, et al.
Published: (2024-11-01) -
Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy?
by: Sajal Ajmani
Published: (2019-01-01)